H. Kaya Et Al. , "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study," EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1, 2024
Kaya, H. Et Al. 2024. Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study. EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1 .
Kaya, H., Öksüzler Kızılbay, G., Ilgazlı, A. H., & Özgür, E. G., (2024). Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study. EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1.
Kaya, Hüseyin Et Al. "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study," EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1, 2024
Kaya, Hüseyin Et Al. "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study." EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1, 2024
Kaya, H. Et Al. (2024) . "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study." EURASIAN JOURNAL OF PULMONOLOGY , vol.2024, no.1.
@article{article, author={Hüseyin Kaya Et Al. }, title={Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study}, journal={EURASIAN JOURNAL OF PULMONOLOGY}, year=2024}